img hero roche nextgen
HealthStrategic ForesightPA & Ecosystem shapingHealth & Pharma

A new era of opportunities

ClientRoche Next-Gen
WhereSpain
WhatHealth & Pharma
When2021-2023

+270 budget lines analyzed ------ 10M of funds raised dedicated to generating positive impact ------ Complete monitoring of government notifications

img modulo 02 roche nextgen

01

THE CHALLENGE

img modulo 03 roche nextgen

Exploring the NextGen horizon

In 2020, the European Union created the NextGenerationEU funds in order to address in a joint effort one of the worst social and economic crises of recent times: the Covid-19 pandemic. These funds have a dual intention, as they also seek to boost the construction of a renewed Europe, focusing efforts on four main areas: ecological transition, digital transformation, social and territorial cohesion, and gender equality.

Time for action

Spain has the possibility of receiving up to 140 billion euros earmarked for project and reform financing. This represents an unprecedented opportunity for companies to generate proposals aligned with the objectives of the European Union to access this funding.

img modulo 04 roche nextgen

A challenge of analysis and opportunity discovery

For Roche, with a focus linked to health system transformation and positive impact, the number of opportunities is enormous. The challenge: link 270 lines of funding from the Spanish government's extensive Resilience Plan (over 4000 pages) with the company's broad portfolio of innovation services. Addressing this requires agility to capitalize on short- and medium-term opportunities and mobilize the entire organization. They are therefore looking for an E2E partner to help them meet this challenge head on.

img modulo 05a roche nextgen
img modulo 05b roche nextgen

02

THE SOLUTION

The courage to navigate uncharted waters

Due to the complexity of the plan, we collaborated closely with Hill+Knowlton, our sister agency specializing in Public Affairs. We broke down the content and created a radar that alerts companies to the most appropriate calls for proposals for their challenges. Participating in these calls requires a significant investment, so this partnership allows us to stay on top of opportunities and make more informed decisions by carefully selecting the best options.

img modulo 06 roche nextgen

An all-encompassing perspective

So-called Expressions of Interest, a channel created by the government to engage in discussions with the private sector, are critical. Our key collaboration with H+K streamlines interaction with the public administration, facilitating the co-creation of projects and accelerating private investment. Collaboration with patient societies, scientific and ministerial partners allows us to present projects with real and measurable impact. After understanding the dimensions of the project and dialoguing with the institutions responsible for the calls for proposals, we identified the 15 most strategic budget lines for Roche, establishing new KPIs and adopting an approach focused on health and social impact.

img modulo 07 roche nextgen

"A good mix of capabilities to solve the complexity of PRTR and capture the opportunity fast".

Teresa Ramos - Head of Personalized Medicine @ ROCHE

TIMELINE

2020

2021

2021

The European Commission shapes the NextGenEU plan principles, with over €100 billion for projects aligned with EU growth priorities. We proactively work to inform and prepare companies.
We created a call radar with H+K to capitalise on opportunities for Roche. We contact patient societies and scientific entities to co-design digital solutions to health challenges.
We initiated a dialogue with the Public Administration, adapting our proposals and devising new solutions in the Manifestations of Interest.

CONCLUSION

A comprehensive analysis of opportunities in NextGen funds for Roche.

img conclusiona roche nextgen
img conclusionb roche nextgen

THE RESULT

The integration of diverse capabilities within our group, both internal and external, has resulted in multiple initiatives; some of them are already successful projects. One such initiative is the development of a precision medicine registry for tumors. This registry integrates a national database of oncology therapies to improve collaborations between research societies. It also facilitates the connection between studies and patients with specific genetic mutations and helps to apply artificial intelligence algorithms to advance in this direction

4000
pages of theNextGen Funds budget plan

Analyzed.

10M €
of funds raised

To generate positive impact.

6
different initiatives

Successfully presented.